All Infection Prevention & Control articles – Page 6
-
NewsFatal infection risk in newborns may increase when this bacteria and fungus mix
A new study reveals that when Streptococcus agalactiae (GBS) interacts with Candida albicans, GBS is more likely to spread disease and become harder to treat in newborns. Infection by both microbes reduces the effectiveness of existing GBS treatments.
-
NewsDiscovery could lead to new treatments for drug-resistant fungal infections
Researchers have identified a molecule that may help turn the tide on fungal infections — butyrolactol A, a chemical compound that targets a deadly, disease-causing fungi called Cryptococcus neoformans.
-
NewsInternational experts connect infections and aging through cellular senescence
Researchers propose the concept of infection-driven senescence (IDS) to describe the phenomenon in which microbial agents, beyond viruses, can trigger cellular senescence in host cells.
-
NewsNew clinical standards strengthen antimicrobial stewardship in tuberculosis care
An international panel of experts from 32 countries has presented specific antimicrobial stewardship standards for TB care for the first time.
-
NewsNew database to target chronic UTIs – a long-overlooked condition that may begin in childhood
A new database targeting chronic urinary tract infections (UTIs) – a long-overlooked condition that may begin in childhood – is set to help researchers uncover why millions of women and girls worldwide suffer from infections that defy treatment and stump microbiologists.
-
NewsHigh levels of Chagas disease parasite found in bugs near US-Mexico border
Researchers have found unusually high levels of parasitic infection in the insects that transmit Chagas disease in the Borderlands. The bugs were collected near homes and natural areas along the U.S.-Mexico border.
-
NewsCFA publishes timely new industry-led UK Ready to Eat Foods Safety and Shelf Life Guidance
New industry-led good practice guidance for manufacturers and retailers of certain ready to eat (RTE) foods will be published on 12 January 2026 to help Food Business Operators (FBOs), Competent Authorities (CAs) and enforcement officers manage the risk posed by Listeria monocytogenes in those products.
-
NewsCandida auris: genetic process revealed which could be treatment target for deadly fungal disease
Scientists have discovered a genetic process which could unlock new ways to treat a mysterious and deadly fungal infection which has shut down multiple hospital intensive care units.
-
NewsHigh-dose antibiotic does not reduce mortality in tuberculous meningitis
The first trial examining the effects of higher rifampicin doses on tuberculosis survival has been completed. The study found no evidence of a beneficial effect from high-dose rifampicin.
-
NewsFiltering the invisible: New evidence points to more efficient indoor air microbe sampling
Using fluorescence-based detection, a new study provides clear, quantitative evidence that sampling principle, collection medium, and airflow rate strongly shape how well indoor microbial aerosols can be measured.
-
NewsNew findings on Candida auris open up potential targets for future therapies
A study shows for the first time that Candida auris uses a CO₂-based metabolic strategy to survive in the nutrient-poor conditions of the skin and to better tolerate antifungal therapies – especially amphotericin B.
-
NewsBeing infected or vaccinated first influences COVID-19 immunity
A new study analysing the immune response to COVID-19 sheds light on an important question: does it matter whether a person was first infected or first vaccinated? According to the results, the order of the events does alter the outcome.
-
NewsScientists identify potential therapy and diagnostic markers for cerebral malaria
Researchers examined whether methylene blue could mitigate brain injury during severe malaria, and whether a practical set of blood biomarkers could help clinicians identify cerebral malaria early and track how patients respond to treatment.
-
NewsCytomegalovirus breakthrough could lead to new treatments
Researchers have developed a new type of antibody with a modified structure that can outsmart cytomegalovirus and neutralize its ability to evade the immune system.
-
NewsReal-world data gives Africa a smarter path to fighting HIV and TB
African biostatisticians have offered a powerful, data-driven alternative that can accurately inform HIV policy, reduce healthcare costs, and save more lives.
-
NewsAn enzyme neutralizes pathogens by cleaving a bacterial toxin
Researchers have discovered an enzyme that neutralizes the virulence factor malleicyprol in the bacterium Burkholderia pseudomallei, considered one of the most dangerous bacterial pathogens in the tropics.
-
NewsYour genes may influence gut microbiome of others, rat study shows
New research, carried out by studying more than four thousand animals, reveals that the composition of the rat gut microbiome is shaped not only by an individual’s own genes but also by the genes of the individuals they share a living space with.
-
NewsSilent dengue infections may hold clues to future vaccine design, study finds
Researchers report the first single-cell immune atlas of asymptomatic dengue, offering a rare look at how the immune system can defeat the virus without triggering illness. The work could help guide the design of safer and more effective dengue vaccines.
-
NewsEvaluation of antiviral activity of organic–polyoxometalate hybrids based on berberine against encephalomyocarditis virus in vitro
A new study promotes the development of POM-based drugs for clinical application by controlling the organic cations on the surface of organic–POM hybrids, ultimately yielding new POM drugs with high efficiency and low toxicity.
-
News4 million euros for study with personalized phage therapy
UMC Utrecht has received a grant of 4 million euros for the first clinical study in the Netherlands involving a customized therapy with bacteriophages for patients with recurrent urinary tract infections.